Pathways of heterocyclic amine activation in the breast:: DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) formed by peroxidases and in human mammary epithelial cells and fibroblasts

被引:25
作者
Williams, JA [1 ]
Stone, EM [1 ]
Millar, BC [1 ]
Hewer, A [1 ]
Phillips, DH [1 ]
机构
[1] Inst Canc Res, Haddow Labs, Sutton SM2 5NG, Surrey, England
关键词
D O I
10.1093/mutage/15.2.149
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Most human mammary carcinomas originate in the epithelial cells of the breast ducts; A potential role of heterocyclic amines (HAs) in the aetiology of this disease has led us to investigate peroxidase-catalysed and stromal (non-epithelial) activation of the HA. 2-amino-3-methylimidazo [4,5-f]quinoline (IQ), which may subsequently lead to DNA damage in the adjacent human mammary epithelial cells (HMECs). HAs are formed when proteinaceous foods are cooked at high temperature and some, but not all, can cause mammary tumours in rats. Myeloperoxidase (MPO) and lactoperoxidase (LPO) are peroxidase enzymes present in breast secretions. P-32-post-labelling analysis showed that IQ-DNA adducts were formed after co-incubation of IQ (500 mu M) with calf thymus DNA, hydrogen peroxide and either bovine LPO or horseradish peroxidase (HRP), The major HRP-mediated IQ-DNA adduct co-migrated on TLC and HPLC with the major adduct formed in HMECs, suggesting a common reactive intermediate (nitrenium ion). IQ-DNA adducts were also formed in extracellular DNA when phorbol myristate acetate-stimulated neutrophils (which activate IQ via MPO) were co-incubated with IQ (500 mu M) and extracellular plasmid (4 +/- 1 adducts/10(8) nucleotides) or calf thymus DNA (6 +/- 2), Mean adduct formation was five to seven times greater in neutrophil DNA (31 +/- 20), Primary cultures of human mammary fibroblasts or epithelial cells isolated from reduction mammoplasty tissues (n = 4 individuals) were incubated with IQ (500 mu M) and formed 2.5 and 14.8 adducts/10(8) nucleotides (mean values), respectively. Our results indicate the possible contribution of stromal cells and breast peroxidases to the metabolic activation of carcinogens in the mammary gland.
引用
收藏
页码:149 / 154
页数:6
相关论文
共 52 条
[41]   MOLECULAR DOSIMETRY OF AROMATIC-AMINES IN HUMAN-POPULATIONS [J].
SKIPPER, PL ;
TANNENBAUM, SR .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1994, 102 :17-21
[42]   Interindividual variation in the metabolic activation of heterocyclic amines and their N-hydroxy derivatives in primary cultures of human mammary epithelial cells [J].
Stone, EM ;
Williams, JA ;
Grover, PL ;
Gusterson, BA ;
Phillips, DH .
CARCINOGENESIS, 1998, 19 (05) :873-879
[43]  
STONE EM, 1999, MUTAGENESIS, V14, P652
[44]   OXIDANT-DEPENDENT METABOLIC-ACTIVATION OF POLYCYCLIC AROMATIC-HYDROCARBONS BY PHORBOL ESTER-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES - POSSIBLE LINK BETWEEN INFLAMMATION AND CANCER [J].
TRUSH, MA ;
SEED, JL ;
KENSLER, TW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (15) :5194-5198
[45]   PEROXIDASE-CATALYZED BENZIDINE BINDING TO DNA AND OTHER MACROMOLECULES [J].
TSURUTA, Y ;
JOSEPHY, PD ;
RAHIMTULA, AD ;
OBRIEN, PJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 1985, 54 (02) :143-158
[46]   CHARACTERIZATION OF DNA ADDUCTS FORMED INVITRO BY REACTION OF NORMAL-HYDROXY-2-AMINO-3-METHYLIMIDAZO[4,5-F]QUINOLINE AND NORMAL-HYDROXY-2-AMINO-3,8-DIMETHYLIMIDAZO[4,5-F]QUINOXALINE AT THE C-8 AND N-2 ATOMS OF GUANINE [J].
TURESKY, RJ ;
ROSSI, SC ;
WELTI, DH ;
LAY, JO ;
KADLUBAR, FF .
CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (04) :479-490
[47]   Molecular cloning and characterization of the chromosomal for human lactoperoxidase [J].
Ueda, T ;
Sakamaki, K ;
Kuroki, T ;
Yano, I ;
Nagata, S .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :32-41
[48]   Diet, nutrition, and avoidable cancer [J].
Willett, WC .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1995, 103 :165-170
[49]   Determination of the enzymes responsible for activation of the heterocyclic amine 2-amino-3-methylimidazo [4,5-f]quinoline in the human breast [J].
Williams, JA ;
Stone, EM ;
Millar, BC ;
Gusterson, BA ;
Grover, PL ;
Phillips, DH .
PHARMACOGENETICS, 1998, 8 (06) :519-528
[50]  
YU MC, 1981, BRIT J CANCER, V43, P826, DOI 10.1038/bjc.1981.121